Aegerion Pharmaceuticals Mergers and Acquisitions Summary

Life Science Company

Aegerion Pharmaceuticals has acquired 1 company of its own.

Aegerion Pharmaceuticals’ largest acquisition to date was in 2014, when it acquired Myalept for $325M. Aegerion Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include medical products (100%).

Join Mergr and gain access to Aegerion Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Aegerion Pharmaceuticals, Inc.

One Main Street, Suite 1850,
Cambridge, Massachusetts 02142
United States,
(617) 500-7867
www.aegerion.com

Aegerion Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of pharmaceutical products to treat cardiovascular and metabolic diseases. Aegerion Pharmaceuticals, Inc. was formed in 2005 and is headquartered in Cambridge, Massachusetts.


M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (0.0/yr) # 1 - - - - - 1
vol $325M $325M
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Myalept 2014-11-06 325M USD Divestiture
, United States · www.myaleptrems.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Medical Products 1 (100%) 325M (100%) - -
Total 1 $325M - -

By Geo

State/Country Buy Value Sell Value
United States 1 325M - -
Total 1 $325M - -

Deal Values

buy # Total
$100M to $1B 1 $325M
TOTAL $325M
Largest Myalept
$325M (2014-11-06)

M&A Connections

Deals
Acquired from
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 163,777
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.1K Private Equity Firms
  • 152K M&A Transactions
  • 160K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.2K M&A Advisors
    (Investment Banks and Law Firms)
  • 49K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.